Medacta posts robust profitability and boosts midterm growth outlook
Medacta reported fiscal 2025 results showing adjusted EBITDA and margins above expectations, strong operating cash flow growth, and higher midterm revenue targets. The company cited foreign exchange headwinds that weighed on gross margins but delivered cost savings and significant capital investment aimed at surgical instruments and production capa…